Aromasin vs Arimidex – Key Differences for Estrogen Control & PCT

When it comes to managing estrogen levels during or after an anabolic steroid cycle, two of the most well-known aromatase inhibitors (AIs) are Aromasin (Exemestane) and Arimidex (Anastrozole). Both play a critical role in post-cycle therapy (PCT) and in-cycle estrogen control, but how do they really compare?

Aromasin, or Exemestane, is a steroidal aromatase inhibitor used to block the enzyme that converts androgens into estrogen. It’s considered a “suicidal” AI, meaning it binds irreversibly to the aromatase enzyme. This makes it effective even after discontinuation. You can buy pharmaceutical-grade Aromasin here.

Arimidex, or Anastrozole, is a non-steroidal AI commonly prescribed for estrogen control in breast cancer patients and by athletes during anabolic steroid cycles. It’s a reversible inhibitor, meaning it binds temporarily and loses effectiveness once discontinued.

If you’re running a strong bulking cycle with aromatizing compounds like testosterone enanthate or dianabol, Arimidex may provide faster estrogen suppression. On the other hand, Aromasin is a better option for preventing estrogen rebound during PCT, especially when combined with Clomid or Nolvadex.

Both compounds can lead to low estrogen if overdosed, causing joint pain, low libido, and fatigue. However, Arimidex is more likely to disrupt cholesterol levels. Aromasin, being mildly androgenic, may support a smoother transition into PCT with fewer lipid profile issues.

Both AIs are commonly used during cycles involving aromatizing steroids like:

For example, athletes stacking testosterone and dianabol often use Arimidex in-cycle, then switch to Aromasin for PCT control and recovery.

When it comes to managing estrogen levels during or after an anabolic steroid cycle, two of the most well-known aromatase inhibitors (AIs) are Aromasin (Exemestane) and Arimidex (Anastrozole). Both play a critical role in post-cycle therapy (PCT) and in-cycle estrogen control, but how do they really compare?

Aromasin, or Exemestane, is a steroidal aromatase inhibitor used to block the enzyme that converts androgens into estrogen. It’s considered a “suicidal” AI, meaning it binds irreversibly to the aromatase enzyme. This makes it effective even after discontinuation. You can buy pharmaceutical-grade Aromasin here.

Arimidex, or Anastrozole, is a non-steroidal AI commonly prescribed for estrogen control in breast cancer patients and by athletes during anabolic steroid cycles. It’s a reversible inhibitor, meaning it binds temporarily and loses effectiveness once discontinued.

If you’re running a strong bulking cycle with aromatizing compounds like testosterone enanthate or dianabol, Arimidex may provide faster estrogen suppression. On the other hand, Aromasin is a better option for preventing estrogen rebound during PCT, especially when combined with Clomid or Nolvadex.

Both compounds can lead to low estrogen if overdosed, causing joint pain, low libido, and fatigue. However, Arimidex is more likely to disrupt cholesterol levels. Aromasin, being mildly androgenic, may support a smoother transition into PCT with fewer lipid profile issues.

Both AIs are commonly used during cycles involving aromatizing steroids like:

For example, athletes stacking testosterone and dianabol often use Arimidex in-cycle, then switch to Aromasin for PCT control and recovery.